National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 1450449

History of Changes from the VAERS Wayback Machine

First Appeared on 7/9/2021

VAERS ID: 1450449
VAERS Form:2
Vaccin­ation / Manu­facturer Lot / Dose Site / Route

Administered by: Private      Purchased by: ??
Symptoms: Full blood count, Gestational diabetes, Haemorrhage in pregnancy, Pre-eclampsia, Protein urine, Ultrasound antenatal screen, Vaginal haemorrhage, Foetal non-stress test, Metabolic function test, Exposure during pregnancy, Blood loss anaemia

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 4     Extended hospital stay? No
Previous Vaccinations:
Other Medications: Protonix 20mg once daily, Prenatal Vitamin once daily, vitamin D 400iu daily, aspirin 81mg daily, tums 750mg chewable 2 tabs as needed for heartburn, acetaminophen 650mg every 6 hours as needed.
Current Illness: none
Preexisting Conditions: none
Allergies: zithromax
Diagnostic Lab Data: 24 hour urine, CBC, CMP, blood pressure monitoring, ultrasound, fetal non stress test weekly
CDC 'Split Type':

Write-up: Estimated delivery date of August 5th, 2021. Currently 35 weeks. Development of preeclampsia, gestational diabetes at 34 weeks. 2 episodes of heavy vaginal bleeding during pregnancy, one at 30 weeks (just after 2nd dose of moderna vaccine) and one at 34 weeks. Currently being monitored for worsening preeclampsia with plans to deliver at 37 weeks (July 15, 2021) if stable. Gestational diabetes managed with diet and exercise at this time. Bleeding resolved within 2 or 3 days. Developed anemia after second bleeding episode.

New Search

Link To This Search Result:

Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166